[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![OzmosiHealth Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1055982930.png) Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2628 followers
Created: 2025-07-21 11:02:05 UTC

$BMY Bristol Myers Squibb's sNDA for Sotyktu (deucravacitinib) in treating active Psoriatic Arthritis accepted for review in four regions worldwide.

More Info: $XBI $IBB $XPH $PPH

![](https://pbs.twimg.com/media/GwYGNo6aAAAVG7a.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947250723793866964/c:line.svg)

**Related Topics**
[$pph](/topic/$pph)
[$xph](/topic/$xph)
[$ibb](/topic/$ibb)
[$xbi](/topic/$xbi)
[more info](/topic/more-info)
[$bmy](/topic/$bmy)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/OzmosiHealth/status/1947250723793866964)